RTN4 and demyelinating disease: RTN4 (also known as Nogo) is a myelin-associated protein that inhibits axon outgrowth in the central nervous system, and has exhibited great potential as a therapeutic target for treating demyelinating diseases and spinal cord injuries [44,45].